United-Guardian, Inc.  

(Public, NASDAQ:UG)   Watch this stock  
Find more results for UG
22.56
+0.36 (1.60%)
Real-time:   10:14AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 22.50 - 22.70
52 week 17.55 - 33.03
Open 22.50
Vol / Avg. 955.00/9,626.00
Mkt cap 103.68M
P/E 24.83
Div/yield 0.50/3.64
EPS 0.91
Shares 4.60M
Beta -0.07
Inst. own 19%
Aug 6, 2015
Q2 2015 United-Guardian Inc Earnings Release (Estimated) Add to calendar
May 14, 2015
United Group for Publishing Advertising and Marketing SA Annual Shareholders Meeting
May 6, 2015
Q1 2015 United-Guardian Inc Earnings Release
Mar 23, 2015
Q4 2014 United-Guardian Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 33.40% 30.12%
Operating margin 47.25% 41.01%
EBITD margin - 42.17%
Return on average assets 34.28% 25.64%
Return on average equity 37.79% 27.96%
Employees 32 -
CDP Score - -

Address

230 Marcus Blvd.
HAUPPAUGE, NY 11788
United States - Map
+1-631-2730900 (Phone)
+1-631-2730858 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

United-Guardian, Inc. is an integrated research, development, manufacturing, and marketing company. The Company supply products to the personal care, health care, industrial, and pharmaceutical sectors. The company's products are developed and manufactured by its Guardian Laboratories Division. The personal care and cosmetic ingredients are marketed through a worldwide network of marketing partners and distributors. The pharmaceuticals are sold to full-line drug wholesalers, which distribute them to pharmacies, hospitals, physicians, long-term care facilities, and other health care providers. The health care products are marketed to manufacturers of medical devices and other medical products, which incorporate them into their finished products and distribute them to hospitals, pharmacies, and other health care facilities. The Company’s two major product lines, Lubrajel and Renacidin Irrigation (Renacidin) together accounted for 94.4% of revenue as of December 31, 2013.

Officers and directors

Kenneth H. Globus Chairman of the Board, President, General Counsel
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Rubinger Chief Financial Officer, Executive Vice President, Treasurer, Secretary, Director
Age: 72
Bio & Compensation  - Reuters
Peter A. Hiltunen Vice President
Age: 56
Bio & Compensation  - Reuters
Joseph J. Vernice Vice President
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Roseann LaCorte Controller
Age: 48
Bio & Compensation  - Reuters
Andrew A. Boccone Independent Director
Age: 69
Bio & Compensation  - Reuters
Arthur M. Dresner Independent Director
Age: 73
Bio & Compensation  - Reuters
Lawrence F. Maietta Independent Director
Age: 57
Bio & Compensation  - Reuters
Christopher W. Nolan Sr. Independent Director
Age: 50
Bio & Compensation  - Reuters